Business description: Abbott India Limited

Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.

Number of employees: 3,659

Sales by Activity: Abbott India Limited

Fiscal Period: March 2021 (INR) 2022 (INR) 2023 (INR) 2024 (INR) 2025 (INR)

Pharmaceuticals

4.31TCr 4.92TCr 5.35TCr 5.85TCr 6.41TCr

Executive Committee: Abbott India Limited

Manager TitleAgeSince
Director of Finance/CFO 52 06/05/2025
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 14/09/2023
Corporate Officer/Principal 56 01/01/2026
Corporate Officer/Principal - -

Composition of the Board of Directors: Abbott India Limited

Director TitleAgeSince
Chairman 82 01/01/1968
Director/Board Member 69 01/03/2011
Director/Board Member 62 25/04/2018
Director/Board Member 70 01/04/2019
Director/Board Member 61 29/10/2019
Director/Board Member 57 13/06/2024
Director/Board Member 56 01/01/2026

Shareholders: Abbott India Limited

NameEquities%Valuation
74.99 %
1,59,34,048 74.99 % 4 794 M ₹
SBI Funds Management Ltd.
2.322 %
4,93,350 2.322 % 148 M ₹
Canara Robeco Asset Management Co., Ltd. (Invt Mgmt)
1.074 %
2,28,206 1.074 % 69 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.9694 %
2,05,992 0.9694 % 62 M ₹
Axis Asset Management Co. Ltd.
0.8913 %
1,89,390 0.8913 % 57 M ₹

Company details: Abbott India Limited

Abbott India Ltd.

Bandra-Kurla Complex, Godrej BKC

400051, Mumbai

+91 22 5046 1000

http://www.abbott.co.in
address Abbott India Limited(ABBOTINDIA)

Other Pharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
+0.68%-3.56%-4.87%+29.88% 616.05Cr
+0.28%+1.81%+21.74%+217.77% 93TCr
-0.15%+1.85%+56.62%+51.35% 59TCr
+0.13%+4.67%+18.64%+53.88% 41TCr
+2.16%+5.16%+25.45%+32.23% 38TCr
+2.39%+9.59%+32.51%+35.14% 32TCr
+1.52%+6.10%+34.09%+59.90% 31TCr
-0.14%+3.58%+45.68%+10.79% 30TCr
+0.73%-1.60%-45.57%-37.14% 22TCr
+1.00%+2.14%+27.20%+54.85% 20TCr
Average +0.83%+1.02%+21.15%+50.86% 36.58TCr
Weighted average by Cap. +0.68%+1.35%+27.60%+82.82%
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock
  4. Company Abbott India Limited